Cellular studies have shown that Cdx2 confers oncogenic properties to murine hematopoietic stem cells in vitro [8, 9], while turning on its expression in vivo induces myelodysplastic lesions, a few of them evolving into overt leukemia [10]. The gene discussed is CDX2; the disease is leukemia.